
Healthcare giant Merck & Co., Inc. (MRK) operates in two segments, Pharmaceutical and Animal Health. On September 22, 2022, MRK Animal Health announced its definitive agreement to acquire virtual fencing innovator Vence.
Rick DeLuca, president of MRK Animal Health, said, "The acquisition of Vence will broaden our portfolio with complementary products and technologies to advance animal health and well-being as well as outcomes for our customers."